Skip to main content
Medical information Clinical review pending

Cytogenetics

BCL2

The BCL2 test helps identify genetic markers associated with certain cancers, like lymphomas and leukemias, aiding in prognosis and treatment planning. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Bone marrow or peripheral blood sample. A Sodium Heparin Vacutainer (2ml) is typically used.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. A doctor's prescription is generally required, though exceptions may apply for surgery, pregnancy, or travel.
Test priceKSh 10,500

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the BCL2 test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspicion of lymphoma or leukemia
  • ✓Unexplained weight loss
  • ✓Persistent fatigue
  • ✓Frequent infections
  • ✓Swollen lymph nodes
  • ✓Family history of blood cancers
02

In plain language

What this test helps you understand

Identifies genetic markers associated with certain cancers, particularly lymphomas and leukemias, to aid in prognosis and treatment planning.
The BCL2 test is a diagnostic tool used primarily in oncology to identify genetic markers linked to specific cancers, particularly lymphomas and leukemias. Understanding BCL2 gene rearrangements can help determine prognosis and guide treatment strategies. This test is valuable for individuals potentially at risk of developing these cancers, enabling early intervention and personalized care. The test measures rearrangements in the BCL2 gene, which regulates programmed cell death. Abnormalities can lead to cancer cell survival. Detecting these changes helps healthcare providers assess cancer risk and tailor treatment. This test is recommended for individuals with symptoms or risk factors for hematologic malignancies, such as unexplained weight loss, persistent fatigue, frequent infections, swollen lymph nodes, or a family history of blood cancers. Taking the BCL2 test offers advantages including early detection of potential genetic abnormalities, informed treatment decisions, better understanding of prognosis, and personalized treatment plans. Results help guide healthcare providers in making informed decisions. A positive result may indicate BCL2 gene rearrangements, potentially requiring further testing or treatment. A negative result may provide reassurance. Discuss your results with your healthcare provider for full understanding.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. A doctor's prescription is generally required, though exceptions may apply for surgery, pregnancy, or travel.
SampleBone marrow or peripheral blood sample. A Sodium Heparin Vacutainer (2ml) is typically used.
MethodologyConfirm with the laboratory before booking.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects specific genetic rearrangements. It may not identify all types of cancer or all genetic abnormalities associated with cancer. Results should be interpreted in the context of the patient's overall clinical picture.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The BCL2 test is primarily used in oncology to help identify genetic markers associated with certain cancers, especially lymphomas and leukemias, aiding in diagnosis, prognosis, and treatment planning.
Individuals with symptoms suggestive of hematologic malignancies (like unexplained weight loss, fatigue, swollen lymph nodes) or a family history of blood cancers may be advised by their doctor to consider this test.
The test typically requires a sample of bone marrow or peripheral blood collected in a Sodium Heparin Vacutainer.
Turnaround time varies. Please confirm the specific turnaround time with the laboratory before booking your test.
Generally, yes, a doctor's prescription is required. However, exceptions may apply for specific situations like pre-surgery, pregnancy, or international travel. Confirm with the laboratory.
Yes, DNA Labs Kenya offers a home sample collection service for your convenience. Please inquire about availability and booking procedures.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp